Market Place
Sourcing Support
Adaptive Biotechnologies to Join Morgan Stanley Global Conference
27 Aug 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies Posts Q2 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies` Q2 2025 Financial Results Due August 5
15 Jul 2025 //
GLOBENEWSWIRE
clonoSEQ® MRD Testing Integrated into OncoEMR®
01 Jul 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies Presents New Data at 2025 ASCO & EHA
30 May 2025 //
GLOBENEWSWIRE
Adaptive Biotech at Goldman Sachs Global Healthcare Conference
28 May 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Q1 2025 Financial Results
01 May 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Report Q1 2025 Results on May 1
10 Apr 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies gets Medicare coverage for clonoSEQ®
08 Apr 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies Enhances clonoSEQ® for Lymphoma MRD
11 Mar 2025 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Q4 & FY 2024 Results
11 Feb 2025 //
GLOBENEWSWIRE
Adaptive Biotech to Participate in Upcoming Investor Conferences
05 Feb 2025 //
GLOBENEWSWIRE
Adaptive Biotech to Report Q4 & Full Year 2024 Results on Feb 11
22 Jan 2025 //
GLOBENEWSWIRE
Adaptive Bio & NeoGenomics Expand Cancer Disease Monitoring Access
14 Jan 2025 //
GLOBENEWSWIRE
Adaptive`s $2,007 clonoSEQ Test Rate Effective January 1, 2025
07 Jan 2025 //
GLOBENEWSWIRE
Adaptive Biotech to Present at 43rd Annual J.P. Morgan Conference
02 Jan 2025 //
GLOBENEWSWIRE
Adaptive`s MRD Testing Advances Blood Cancer Treatment With clonoSEQ®
07 Dec 2024 //
GLOBENEWSWIRE
Adaptive Biotech Presents 65+ Abstracts at ASH Annual Meeting
03 Dec 2024 //
GLOBENEWSWIRE
Adaptive Biotech Expands Medicare Coverage for clonoSEQ® in MCL
07 Nov 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies To Report Q3 2024 Results November 7
09 Oct 2024 //
GLOBENEWSWIRE
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
29 Aug 2024 //
GLOBENEWSWIRE
Adaptive Biotech To Attend Morgan Stanley Healthcare Conference
22 Aug 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
01 Aug 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies To Report Q2 2024 Results On August 1
11 Jul 2024 //
GLOBENEWSWIRE
Adaptive`s clonoSEQ MRD Data At ASCO, EHA For Clinical Benefits
31 May 2024 //
GLOBENEWSWIRE
Adaptive At Goldman Sachs Healthcare Conference 2024
29 May 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
06 May 2024 //
GLOBENEWSWIRE
Adaptive Biotech Reports Q1 2024 Financials on May 7, 2024
17 Apr 2024 //
GLOBENEWSWIRE
Adaptive Provides Strategic Review Update & Announces First Quarter 2024 Revenue
02 Apr 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast
27 Mar 2024 //
GLOBENEWSWIRE
Adaptive Bio to Present at the TD Cowen 44th Annual Healthcare Conference
22 Feb 2024 //
GLOBENEWSWIRE
Adaptive Bio Reports Fourth Quarter and Full Year 2023 Financial Results
14 Feb 2024 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Report Fourth Quarter 2023 Financial Results
29 Jan 2024 //
GLOBENEWSWIRE
Adaptive Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
27 Dec 2023 //
GLOBENEWSWIRE
Adaptive Announces New Data Highlighting the Clinical Relevance of MRD Testing
09 Dec 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts
05 Dec 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Adaptive Announces Collaboration to Measure Minimal Residual Disease
07 Nov 2023 //
GLOBENEWSWIRE
Adaptive Bio to Report Third Quarter Financial Results on November 9, 2023
02 Nov 2023 //
GLOBENEWSWIRE
Adaptive Announces Launch of Epic Integration for clonoSEQ®
13 Sep 2023 //
GLOBENEWSWIRE
Adaptive to Participate in the Morgan Stanley 21st Annual Conference
30 Aug 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Report Q2 Financial Results on August 2, 2023
10 Jul 2023 //
GLOBENEWSWIRE
Adaptive Highlights Data at ASCO and EHA Underscoring the clonoSEQ Assay Impact
02 Jun 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
24 May 2023 //
GLOBENEWSWIRE
Adaptive to Participate in 2023 RBC Capital Markets Global Healthcare Conference
12 May 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies Announces FDA Acceptance of Genentech™ISNDA
09 May 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports 1Q 2023 Financial Results
03 May 2023 //
GLOBENEWSWIRE
Adaptive to Participate in the BofA Securities 2023 Healthcare Conference
25 Apr 2023 //
GLOBENEWSWIRE
Adaptive Bio to Report First Quarter Financial Results on May 3, 2023
06 Apr 2023 //
GLOBENEWSWIRE
Adaptive to Participate in the 43rd Annual Cowen Healthcare Conference
27 Feb 2023 //
GLOBENEWSWIRE
Adaptive Reports Fourth Quarter and Full Year 2022 Financial Results
14 Feb 2023 //
GLOBENEWSWIRE
Adaptive Biotech to Report Fourth Quarter and Full Year 2022 Financial Results
23 Jan 2023 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Conference
27 Dec 2022 //
GLOBENEWSWIRE
Adaptive Highlights Data Showcasing the Utility of clonoSEQ MRD Testing
10 Dec 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts
05 Dec 2022 //
GLOBENEWSWIRE
Adaptive Announces Launch of clonoSEQ® to Assess (MRD) Patients(DLBCL, ctDNA)
01 Dec 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies to Participate in Piper Sandler Healthcare Conference
21 Nov 2022 //
GLOBENEWSWIRE
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
PRESS RELEASE
